Chlorothiazide sodium side effects by duration, gender and age - a phase IV clinical study of FDA data

Summary:

Side effects are reported by people who take Chlorothiazide sodium. Common side effects include white blood cell count increased among females and hyperparathyroidism secondary among males.

The phase IV clinical study is created by eHealthMe based on 33 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 13, 2022

33 people who take Chlorothiazide Sodium and have side effects are studied.


What is Chlorothiazide Sodium?

Chlorothiazide sodium has active ingredients of chlorothiazide sodium. eHealthMe is studying from 34 Chlorothiazide sodium users for its effectiveness, alternative drugs and more.

Number of Chlorothiazide sodium reports submitted per year:

Chlorothiazide sodium side effects.

Chlorothiazide Sodium side effects by time on the drug*:

< 1 month:

  1. Haemorrhage (bleeding)

1 - 6 months:

n/a

6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:

n/a

10+ years:

n/a

not specified:

  1. White blood cell count increased
  2. Spinal fracture (fracture in one of vertebrae)
  3. Terminal state (the transitional states between life and biological death)
  4. Ventricular extrasystoles (premature cardiac contraction)
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
  7. Tooth loss
  8. Hospitalisation
  9. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  10. Injection site calcification

Chlorothiazide Sodium side effects by gender *:

female:

  1. White blood cell count increased
  2. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  3. Ventricular extrasystoles (premature cardiac contraction)

male:

  1. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  2. Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
  3. Tooth loss
  4. Haemorrhage (bleeding)
  5. Hospitalisation
  6. Pulmonary oedema (fluid accumulation in the lungs)
  7. Right ventricular dysfunction
  8. Spinal fracture (fracture in one of vertebrae)
  9. Terminal state (the transitional states between life and biological death)
  10. White blood cell count increased

Chlorothiazide Sodium side effects by age (0-1 to 60+) *:

0-1:

  1. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  2. Hospitalisation
  3. White blood cell count increased

2-9:

  1. Terminal state (the transitional states between life and biological death)
  2. Pulmonary oedema (fluid accumulation in the lungs)

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Tooth loss
  2. Spinal fracture (fracture in one of vertebrae)

50-59:

  1. Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
  2. White blood cell count increased

60+:

  1. Haemorrhage (bleeding)
  2. Ventricular extrasystoles (premature cardiac contraction)

* Approximation only. Some reports may have incomplete information.

Do you take Chlorothiazide sodium?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



How the study uses the data?

The study is based on chlorothiazide sodium (the active ingredients of Chlorothiazide sodium) and Chlorothiazide sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.

Related studies

Alternative drugs to, pros and cons of Chlorothiazide sodium:

All Chlorothiazide sodium side effects from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: